Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Targeted Anticancer Therapies Congress 2024

The quest for dosage and combination optimisation in early drug development

Statistical and study design considerations for dose-finding and dose optimisation in early-phase oncology trials

Date

28 Feb 2024

Session

The quest for dosage and combination optimisation in early drug development

Topics

Statistics

Tumour Site

Presenters

Pavel Mozgunov

Authors

P. Mozgunov

Author affiliations

  • University of Cambridge, CB2OQQ - Cambridge/GB

Resources

This content is available to ESMO members and event participants.
Login

Resources from the same session

Panel discussion

Presenter: All Speakers

Session: The quest for dosage and combination optimisation in early drug development

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.